Gregory Friedman, M.D., Pediatric Hematology & Oncology, was invited to attend and speak at the WhatIFF Symposium for Pediatric Brain Tumor Research on Sept. 15-16 in Atlanta, GA. This first ever symposium for pediatric brain tumor research gathered the top clinicians and researchers in the field to present their ideas on how to put an end to brain tumors. Dr. Friedman's talk titled, "Immunovirotherapy to Target Pediatric Brain Tumors” discussed the ongoing oncolytic HSV trial at Children's of Alabama and plans to develop innovative combination approaches to maximize virus killing of cancer cells and the development of an anti-tumor immune response. Dr. Friedman Presents at WHATIFF Symposium for Pediatric Brian Tumor Research
Gregory Friedman, M.D., Pediatric Hematology & Oncology, was invited to attend and speak at the WhatIFF Symposium for Pediatric Brain Tumor Research on Sept. 15-16 in Atlanta, GA. This first ever symposium for pediatric brain tumor research gathered the top clinicians and researchers in the field to present their ideas on how to put an end to brain tumors. Dr. Friedman's talk titled, "Immunovirotherapy to Target Pediatric Brain Tumors” discussed the ongoing oncolytic HSV trial at Children's of Alabama and plans to develop innovative combination approaches to maximize virus killing of cancer cells and the development of an anti-tumor immune response.